The KLLN Knockout HeLa Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HeLa cervical adenocarcinoma cell line, with targeted disruption of the KLLN tumor suppressor gene. This loss-of-function model enables investigation of killin protein function in a heterogeneous cell population, bypassing the artifacts associated with clonal selection. The polyclonal format preserves genetic diversity, allowing robust assessment of KLLN-dependent phenotypes in a cancer-relevant context. The cells are suitable for immediate culture and downstream functional analyses.
The parental HeLa cell line is an immortalized human epithelial cell line established from a cervical adenocarcinoma, widely used as a model for human cell biology. HeLa cells are HPV18-positive, leading to degradation of the endogenous tumor suppressor p53 through the viral E6 oncoprotein. This characteristic renders them particularly useful for studying p53-independent signaling pathways and DNA damage responses. Their well-characterized, rapidly proliferating phenotype and extensive historical data make them an ideal host for gene knockout experiments.
KLLN encodes killin, a nuclear protein that functions as a critical tumor suppressor downstream of p53. Killin is transcriptionally activated by p53 and exerts its anti-proliferative effects by directly interacting with proliferating cell nuclear antigen (PCNA) and the minichromosome maintenance (MCM2?C7) complex, thereby disrupting pre-replication complex assembly and inhibiting DNA synthesis. This interaction causes S-phase arrest. In parallel, killin promotes apoptosis via the intrinsic mitochondrial pathway, upregulating BAX and triggering caspase-3 activation. Thus, KLLN integrates p53-mediated growth inhibition and programmed cell death through its molecular associations with PCNA, MCM2-7, BAX, and caspase-3. These combined actions position killin as a key effector of p53-dependent tumor suppression.
Given the HeLa cell background, the KLLN knockout model is particularly valuable for investigating killin??s tumor suppressor functions in a p53-null environment. The absence of functional p53 in HeLa cells, due to HPV18 E6-mediated degradation, forces KLLN regulation and function to be examined independently of its canonical upstream activator. This system thus enables dissection of p53-independent modes of killin activity and its role in intrinsic apoptosis, DNA replication control, and cell cycle checkpoint regulation. Research on KLLN is directly relevant to Cowden syndrome, hamartoma tumor syndromes, glioblastoma multiforme, and carcinomas of the prostate and breast, underscoring the broad significance of this knockout model.
This polyclonal knockout cell population is optimized for cancer biology studies, including tumor suppressor functional assays, p53 pathway investigation, DNA replication inhibition analyses, and apoptosis research. Compatible techniques encompass western blotting for KLLN, RT-qPCR for KLLN and p53 targets, immunofluorescence to visualize PCNA localization, flow cytometry for apoptosis, cell cycle analysis, BrdU incorporation, clonogenic survival assays, and co-immunoprecipitation of KLLN-PCNA complexes. The polyclonal format ensures population-level heterogeneity, improving translatability for drug response experiments. For detailed technical data or to request a quote, please reach out to Ascent Research.
